American Express
AXP
Bank of America
BAC
Occidental Petroleum
OXY
4
Citigroup
C
5
Chevron
CVX
US Stock MarketDetailed Quotes
ABUS Arbutus Biopharma
- 3.300
- -0.020-0.60%
Close Mar 14 16:00 ET
- 3.300
- 0.0000.00%
Post 20:01 ET
625.32MMarket Cap-7.67P/E (TTM)
3.405High3.285Low707.42KVolume3.340Open3.320Pre Close2.36MTurnover0.53%Turnover RatioLossP/E (Static)189.49MShares4.72552wk High5.85P/B443.26MFloat Cap2.30052wk Low--Dividend TTM134.32MShs Float31.480Historical High--Div YieldTTM3.61%Amplitude0.821Historical Low3.329Avg Price1Lot Size
Arbutus Biopharma News
Strategic Legal Maneuvers Bolster Buy Rating for Arbutus Biopharma Amid Global Patent Challenges
Roivant Sciences Unit, Arbutus File Lawsuits Against Moderna for Alleged Patent Infringement
Express News | Genevant: Seeking Monetary Relief, Injunctions Against Spikevax &, Where Applicable, Additional Products That Moderna Represented Use Same Lnp Tech
Express News | Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
Positive Outlook on Arbutus Biopharma Amid Strategic Focus and Legal Developments
Arbutus Biopharma's Entire Board Replaced as New CEO Steps In
Express News | Arbutus Biopharma Corp - to Pause Investor Meetings During Strategic Review
Express News | Arbutus Biopharma Corp - All Existing Arbutus Board Members Step Down
Press Release: Arbutus Announces Changes to Board of Directors and Appointment of Lindsay Androski as CEO
Arbutus Announces Changes to Board of Directors and Appointment of Lindsay Androski as CEO
Is Arbutus Biopharma Corp. (ABUS) the Best Nasdaq Stock Under $5 to Buy?
Arbutus Biopharma Analyst Ratings
Jim Cramer on Arbutus Biopharma Corporation (ABUS): 'It Loses Money'
Cramer's Lightning Round: Arbutus Biopharma Is 'the Ultimate Spec'
Arbutus Expects to Significantly Reduce Its Net Cash Burn in 2025
Arbutus Provides 2025 Corporate and Financial Update
Jefferies Financial: Arbutus (ABUS.US) will benefit from the Bird Flu vaccine from large pharmaceutical companies.
Jefferies Financial rates Arbutus Stocks as "Buy," with a Target Price of $7.
Arbutus Could Benefit From Big Pharma Bird Flu Vaccines: Jefferies
Antisense & RNAi Therapeutics Market Report 2024, Featuring Profiles of Alnylam Pharmaceuticals, Arbutus Biopharma, Benitec Biopharma, GSK, Ionis Pharmaceuticals, Sanofi, Sarepta Therapeutics & More - ResearchAndMarkets.com
Here's Why Arbutus (ABUS) Surged in Q3
Trending Stocks
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
[2025.2] How should NVIDIA's performance be viewed? The key indicator to watch for short-term stock prices is this.
NVIDIA has been one of the best-performing Technology giants in the US stock market over the past two years, and since 2024, its stock price has experienced sig
How to view Tesla's performance in January 2025? Pay attention to these four key points.
It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th